Loading…
Product type
Gefitinib is an oral medication used primarily in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic mutations. It functions as a tyrosine kinase inhibitor, targeting the epidermal growth factor receptor (EGFR) to inhibit cancer cell proliferation. Gefitinib is synthesized from various chemical compounds and is typically available in tablet form for patient administration.
| Chemical formula | C22H24ClFN4O3 |
| Molecular weight | 446.9 g/mol |
| Purity | Typically ≥ 98% |
| Storage conditions | Store at room temperature, away from moisture |
| Formulation | Tablets, usually 250 mg per tablet |
When selecting gefitinib as an active pharmaceutical ingredient, buyers should consider the required purity levels and the specific formulation needed for their applications. It is also important to verify the supplier's compliance with relevant regulatory standards and certifications. Buyers should specify the desired quantity and any specific storage or handling requirements to ensure product integrity.
Get quotes for Gefitinib
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Gefitinib is primarily used to treat non-small cell lung cancer.
It is administered orally in tablet form.
Common side effects include diarrhea, rash, and liver function changes.
Yes, gefitinib is a prescription medication.
Liver function and potential side effects should be monitored regularly.
Yes, it may be used alongside other cancer therapies, but consult a healthcare professional.